TRIPRIDE -1 TAB

About

TRIPRIDE -1 TAB contains glimepiride, a sulfonylurea medication used to manage type 2 diabetes mellitus. It works by stimulating the beta cells in the pancreas to release more insulin, which helps to lower blood glucose levels. This action is dependent on the presence of functioning pancreatic beta cells. Glimepiride also contributes to improved insulin sensitivity in peripheral tissues and a reduction in hepatic glucose production. It is prescribed when diet, exercise, and weight reduction alone are insufficient to achieve adequate glycemic control. The medication helps patients achieve and maintain their target blood sugar levels, thereby reducing the risk of diabetes-related complications.

Uses

• Management of type 2 diabetes mellitus.
• As an adjunct to diet and exercise.
• Monotherapy for glycemic control.
• In combination with other antidiabetic agents.

Directions For Use

Take orally once daily, preferably with breakfast or the first main meal of the day. Follow your doctor's prescribed dosage and schedule.

Benefits

• Effectively lowers blood glucose levels.
• Reduces HbA1c, improving long-term control.
• Stimulates natural insulin secretion.
• Can be used alone or with other medications.
• Helps achieve target glycemic goals.
• Convenient once-daily administration.

Side Effects

• Hypoglycemia (low blood sugar).
• Weight gain.
• Nausea and vomiting.
• Diarrhea or constipation.
• Abdominal pain.
• Headache.
• Dizziness.
• Allergic skin reactions (e.g., rash, itching).
• Photosensitivity.
• Transient visual disturbances.
• Liver enzyme elevations.
• Blood dyscrasias (rare, e.g., leukopenia).

Safety Measures

• Alcohol - Alcohol can potentiate the hypoglycemic effect of glimepiride; consume with extreme caution or avoid.
• Pregnancy - Not recommended during pregnancy; insulin is generally preferred for glycemic control in pregnant women.
• Breastfeeding - Not advised as glimepiride may pass into breast milk and cause hypoglycemia in the infant.
• Liver - Use with caution in patients with hepatic impairment; dose adjustment may be necessary due to altered metabolism.
• Kidney - Use with caution in patients with renal impairment; dose adjustment is required due to reduced excretion.
• Lung - No specific direct lung contraindication, but severe pulmonary disease may indirectly affect glucose metabolism.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.